Nuvilex Eyes FDA Fast Track After ABRAXANE Approved for Pancreatic Cancer
September 11, 2013 08:45 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Sep 11, 2013) - Nuvilex, Inc. (OTCQB: NVLX) and its shareholders enjoyed what could be a dress rehearsal of their own future with the Food and Drug Administration's...
Nuvilex Contracts Fisher BioServices, Inc. for Long-Term Storage of Cells for Future Phase 3 Clinical Trials
September 10, 2013 09:40 ET
|
Nuvilex, Inc.
SILVER SPRING, MD--(Marketwired - Sep 10, 2013) - Nuvilex, Inc. (OTCQB: NVLX) (Company), an international biotechnology company providing cell and gene therapy solutions for the treatment of...
FDA Approves ABRAXANE(R) for Pancreatic Cancer, Could Nuvilex's Treatment Be Next
September 09, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Sep 9, 2013) - After presenting the results of its large scale Phase III clinical trial at the 2013 Gastrointestinal Cancers Symposium of the American Society of...
Companies With a Stake in the Marijuana Debate Receive More Good News as Feds Stand Down
September 05, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Sep 5, 2013) - The debate to legalize marijuana in this country cleared another hurdle late last week when U.S. Attorney General Eric Holder reached out to the...
Nuvilex Investors Watch as Incyte Shares Rise Sharply on Pancreatic Cancer Trials Data
August 28, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Aug 28, 2013) - As Nuvilex, Inc. (OTCQB: NVLX) continues to methodically build its brand as a biotechnology firm ahead of its future Phase III clinical trials for the...
Drug Makers Could Soon Turn Away From Eli Lilly's Gemzar and Toward Nuvilex's Cell Encapsulation
August 22, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Aug 22, 2013) - While Eli Lilly's cancer fighting drug Gemzar (gemcitabine) has been on the market since the late 1990s, its success with cancer duly noted, other big...
Nuvilex, Inc. Investing Big in What Could Be Its Billion Dollar Future
August 20, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Aug 20, 2013) - Nuvilex, Inc. (OTCQB: NVLX) just acquired oncology assets that make this small Silver Spring, Maryland, biotech worth more today than it was just a...
Nuvilex: The Real Story
August 15, 2013 15:20 ET
|
Nuvilex, Inc.
SAN DIEGO, CA--(Marketwired - Aug 15, 2013) - The OTC Journal, the longest running electronic newsletter focused on the small cap and microcap sectors, wishes to provide accurate information...
Stock Market Media Group Issues Nuvilex, Inc. Road to Phase III Clinical Trials Report
August 15, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Aug 15, 2013) - Stock Market Media Group, a research and content development investor relations firm, issued its Third Quarter Update and the first installment of its...
Nuvilex, Inc. to Control 2 of the Big 3 Multi Billion Dollar Drug Markets With Technology
August 07, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Aug 7, 2013) - Nuvilex, Inc. (OTCQB: NVLX) is methodically laying the foundation today for what should be a very busy and promising future tomorrow. After making a...